Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v6-EN
Language French English
Date Updated 2019-07-08 2019-04-12
Drug Identification Number 02148706 02148706
Brand name NALOXONE HCL INJECTION - 0.4MG/ML USP NALOXONE HCL INJECTION - 0.4MG/ML USP
Common or Proper name NALOXONE HCl Inj NALOXONE HCl Inj
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG 0.4MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X10ml 1X10ml
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-04-05 2019-04-05
Estimated end date 2019-07-08 2019-07-01
Actual end date 2019-06-19
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 150% of historical monthly volumes until return date. Limited inventory is currently available for this product at Sandoz. To maintain our inventory levels and to avoid unanticipated bulk orders, the product will be placed on protective allocation at 150% of historical monthly volumes until return date.
Health Canada comments